Amylyx Pharmaceuticals, Inc. (AMLX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Amylyx Pharmaceuticals, Inc. (AMLX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

AMLX Income Statement

Amylyx Pharmaceuticals, Inc. (AMLX) annual income statement — 7-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	-665K	416K	-1.02M	88.64M	108.45M	102.69M	98.22M	71.43M	21.89M	345K	0	0	0	0
Revenue Growth %	-	-	100%	-100%	100%	-100%	-100.61%	-99.59%	-101.04%	24.1%	395.54%	29666.09%	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	98K	108K	19.86M	141K	22.12M	0	809K	7.63M	116.41M	9.36M	5.22M	5.58M	5.28M	2.82M	172K	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	194.47%	-745.45%	131.32%	8.63%	5.08%	5.68%	7.4%	12.89%	49.86%	-	-	-	-
Gross Profit	0	-98K	-108K	-19.86M	-141K	-22.12M	-665K	-393K	-8.65M	-27.76M	99.09M	97.47M	92.64M	66.14M	19.06M	173K	0	0	0	0
Gross Margin %	-	-	-	-	-	-	100%	-94.47%	845.45%	-31.32%	91.37%	94.92%	94.32%	92.6%	87.11%	50.14%	-	-	-	-
Gross Profit Growth %	100%	99.56%	83.76%	-4952.16%	98.37%	20.33%	-100.67%	-100.4%	-109.34%	-141.97%	419.77%	56243.93%	-	-	-	-	-	-	-	-
Operating Expenses	45.69M	43.78M	36.5M	16.17M	42.72M	15.68M	39.99M	75.27M	44.79M	94.37M	97.16M	78.75M	72.44M	68.2M	63.66M	54.85M	54.25M	47.81M	28.32M	22.92M
OpEx % of Revenue	-	-	-	-	-	-	-6013.38%	18093.27%	-4377.91%	106.46%	89.59%	76.69%	73.75%	95.48%	290.87%	15899.71%	-	-	-	-
Selling, General & Admin	21.93M	16.17M	15.39M	16.17M	15.64M	15.68M	17.1M	17.83M	21.65M	57.76M	52.24M	48.72M	43.39M	44.01M	40.84M	29.94M	29.99M	26.35M	14.92M	10.35M
SG&A % of Revenue	-	-	-	-	-	-	-2570.98%	4285.58%	-2116.03%	65.16%	48.17%	47.44%	44.18%	61.61%	186.63%	8678.26%	-	-	-	-
Research & Development	23.77M	27.61M	21.11M	19.86M	27.08M	22.12M	22.89M	21.24M	23.14M	36.61M	44.91M	30.04M	29.04M	24.19M	22.81M	24.91M	24.26M	21.46M	13.39M	12.85M
R&D % of Revenue	-	-	-	-	-	-	-3442.41%	5105.05%	-2261.88%	41.3%	41.41%	29.25%	29.57%	33.87%	104.24%	7221.45%	-	-	-	-
Other Operating Expenses	0	0	0	-1000K	0	-1000K	0	1000K	0	0	0	0	0	0	0	0	0	0	0	-285K
Operating Income	-45.69M	-43.78M	-36.6M	-36.03M	-42.86M	-37.8M	-40.65M	-75.66M	-53.44M	-122.13M	1.93M	18.72M	20.2M	-2.05M	-44.59M	-54.68M	-54.25M	-47.81M	-28.32M	-22.92M
Operating Margin %	-	-	-	-	-	-	6113.38%	-18187.74%	5223.36%	-137.78%	1.78%	18.23%	20.57%	-2.87%	-203.76%	-15849.57%	-	-	-	-
Operating Income Growth %	-6.62%	-15.81%	9.96%	52.38%	19.8%	69.05%	-2202.07%	-504.17%	-364.52%	-5848.86%	104.34%	134.23%	137.23%	95.71%	-57.49%	-138.59%	-	-	-	-
EBITDA	-45.65M	-43.68M	-36.5M	-35.91M	-42.72M	-37.65M	-40.49M	-75.44M	-53.23M	-121.81M	2.23M	19.02M	20.48M	-1.85M	-44.41M	-54.52M	-54.15M	-47.78M	-28.29M	-22.91M
EBITDA Margin %	-	-	-	-	-	-	6089.32%	-18134.62%	5203.03%	-137.42%	2.06%	18.52%	20.85%	-2.59%	-202.93%	-15801.74%	-	-	-	-
EBITDA Growth %	-6.87%	-16.03%	9.87%	52.4%	19.75%	69.09%	-1911.81%	-496.59%	-359.87%	-6488.16%	105.03%	134.89%	137.83%	96.13%	-56.97%	-137.98%	-	-	-	-
D&A (Non-Cash Add-back)	43K	98K	108K	120K	141K	156K	160K	221K	208K	315K	301K	302K	281K	204K	182K	165K	105K	35K	22K	10K
EBIT	-43.42M	-41.28M	-31.06M	-34.39M	-41.44M	-35.91M	-38.18M	-72.7M	-72.7M	-118.55M	1.93M	18.72M	20.2M	-2.05M	-44.59M	-54.68M	-54.25M	-47.81M	-28.34M	-22.92M
Net Interest Income	2.32M	2.57M	3.29M	1.82M	1.96M	2.23M	2.32M	3.1M	4.07M	4.33M	4.37M	4.18M	3.89M	3.72M	3.16M	601K	402K	131K	30K	3K
Interest Income	2.32M	2.57M	3.29M	1.82M	1.96M	2.23M	2.32M	3.1M	4.07M	4.33M	4.37M	4.18M	3.89M	3.72M	3.16M	601K	402K	131K	30K	3K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	2.27M	2.5M	3.65M	1.64M	1.41M	1.9M	2.47M	2.96M	-19.27M	3.58M	4.54M	3.69M	3.81M	3.46M	2.47M	800K	360K	112K	-29K	-224K
Pretax Income	-43.42M	-41.28M	-32.95M	-34.39M	-41.44M	-35.91M	-38.18M	-72.7M	-72.7M	-118.55M	6.48M	22.41M	24.01M	1.4M	-42.13M	-53.88M	-53.89M	-47.7M	-28.34M	-23.14M
Pretax Margin %	-	-	-	-	-	-	5741.5%	-17476.92%	7106.55%	-133.74%	5.97%	21.82%	24.44%	1.96%	-192.48%	-15617.68%	-	-	-	-
Income Tax	0	0	46K	0	0	0	-635K	0	0	242K	1.75M	1.52M	1.93M	-170K	579K	-125K	174K	146K	0	0
Effective Tax Rate %	0%	0%	-0.14%	0%	0%	0%	1.66%	0%	0%	-0.2%	26.95%	6.77%	8.05%	-12.12%	-1.37%	0.23%	-0.32%	-0.31%	0%	0%
Net Income	-43.42M	-41.28M	-33M	-34.39M	-41.44M	-35.91M	-37.55M	-72.7M	-72.7M	-118.79M	4.73M	20.89M	22.07M	1.57M	-42.7M	-53.76M	-54.07M	-47.85M	-28.34M	-23.14M
Net Margin %	-	-	-	-	-	-	5646.01%	-17476.92%	7106.55%	-134.01%	4.36%	20.35%	22.48%	2.2%	-195.13%	-15581.45%	-	-	-	-
Net Income Growth %	-4.78%	-14.97%	12.11%	52.7%	42.99%	69.77%	-893.62%	-447.98%	-429.35%	-7652%	111.08%	138.87%	140.83%	103.29%	-50.66%	-132.29%	-	-	-	-
Net Income (Continuing)	-43.42M	-41.28M	-33M	-34.39M	-41.44M	-35.91M	-37.55M	-72.7M	-72.7M	-118.79M	4.73M	20.89M	22.07M	1.57M	-42.7M	-53.76M	-54.07M	-47.85M	-28.34M	-23.14M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.39	-0.37	-0.28	-0.37	-0.46	-0.42	-0.55	-1.07	-1.07	-1.75	0.07	0.30	0.31	0.02	-0.65	-0.92	-0.93	-0.93	-0.51	-0.42
EPS Growth %	15.22%	11.9%	49.09%	65.42%	57.01%	76%	-904.09%	-456.67%	-445.16%	-7982.88%	110.52%	132.61%	133.33%	102.39%	-27.45%	-119.05%	-	-	-	-
EPS (Basic)	-0.39	-0.37	-0.28	-0.37	-0.46	-0.42	-0.55	-1.07	-1.07	-1.75	0.07	0.31	0.33	0.02	-0.65	-0.92	-0.93	-0.93	-0.51	-0.42
Diluted Shares Outstanding	111.2M	110.56M	94.57M	93.33M	89.14M	85.7M	68.59M	68.09M	68.02M	67.85M	69.2M	69.75M	70.13M	70.86M	65.42M	58.53M	58.28M	51.6M	55.22M	55.22M
Basic Shares Outstanding	111.2M	110.56M	94.57M	93.33M	89.14M	85.7M	68.59M	68.09M	68.02M	67.85M	67.41M	67.41M	67.23M	66.72M	65.42M	58.53M	58.14M	51.45M	55.22M	55.22M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-